75 related articles for article (PubMed ID: 32360901)
1. Defective O-glycosylation of novel FGF23 mutations in a Chinese family with hyperphosphatemic familial tumoral calcinosis.
Liu C; Pang Q; Jiang Y; Xia Y; Fang L; Wang O; Li M; Xing X; Gong Y; Xia W
Bone; 2020 Aug; 137():115401. PubMed ID: 32360901
[TBL] [Abstract][Full Text] [Related]
2. Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression.
Ichikawa S; Sorenson AH; Austin AM; Mackenzie DS; Fritz TA; Moh A; Hui SL; Econs MJ
Endocrinology; 2009 Jun; 150(6):2543-50. PubMed ID: 19213845
[TBL] [Abstract][Full Text] [Related]
3. Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho).
Farrow EG; Imel EA; White KE
Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):735-47. PubMed ID: 22142751
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis.
Garringer HJ; Malekpour M; Esteghamat F; Mortazavi SM; Davis SI; Farrow EG; Yu X; Arking DE; Dietz HC; White KE
Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E929-37. PubMed ID: 18682534
[TBL] [Abstract][Full Text] [Related]
5. A Cross-Sectional Cohort Study of the Effects of FGF23 Deficiency and Hyperphosphatemia on Dental Structures in Hyperphosphatemic Familial Tumoral Calcinosis.
Lee AE; Chu EY; Gardner PJ; Duverger O; Saikali A; Wang SK; Gafni RI; Hartley IR; Ten Hagen KG; Somerman MJ; Collins MT
JBMR Plus; 2021 May; 5(5):e10470. PubMed ID: 33977199
[TBL] [Abstract][Full Text] [Related]
6. Three Siblings With a Rare Familial Hyperphosphatemia Syndrome: A Case Series.
Sowaity ZA; Saleem JY; Sabooh TN; Dukmak ON; Abu Al-Saoud SY
Cureus; 2024 Mar; 16(3):e55575. PubMed ID: 38576700
[TBL] [Abstract][Full Text] [Related]
7. Spatial Atlas for Mapping Vascular Microcalcification Using 18F-NaF PET/CT: Application in Hyperphosphatemic Familial Tumoral Calcinosis.
Sheppard AJ; Theng EH; Paravastu SS; Wojnowski NM; Farhadi F; Morris MA; Hartley IR; Gafni RI; Roszko KL; Collins MT; Saboury B
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1432-1446. PubMed ID: 38660800
[TBL] [Abstract][Full Text] [Related]
8. Recurrent Bilateral Lower Motor Neuron Type of Facial Palsy with Hearing Impairment: Hyperphosphatemic Familial Tumoral Calcinosis.
Gowda VK; Raj A; Vamyanmane DK; Nagarajappa VH; Srinivas SM; Tirumale R; Ranganath J; Gaddehosur C; Vishwanathan GB
J Pediatr Genet; 2023 Dec; 12(4):280-287. PubMed ID: 38162162
[TBL] [Abstract][Full Text] [Related]
9. Elderly-onset calcinosis of hyperphosphataemic familial tumoural calcinosis/hyperostosis-hyperphosphataemia syndrome: the role of comorbid scleroderma.
Iwasaki H
Endocrinol Diabetes Metab Case Rep; 2023 Oct; 2023(4):. PubMed ID: 37787752
[TBL] [Abstract][Full Text] [Related]
10. Dietary phosphate restriction normalizes biochemical and skeletal abnormalities in a murine model of tumoral calcinosis.
Ichikawa S; Austin AM; Gray AK; Allen MR; Econs MJ
Endocrinology; 2011 Dec; 152(12):4504-13. PubMed ID: 22009723
[TBL] [Abstract][Full Text] [Related]
11. A Sole Case of the FGF23 Gene Mutation c.202A>G (p.Thr68Ala) Associated with Multiple Severe Vascular Aneurysms and a Hyperphosphatemic Variant of Tumoral Calcinosis-A Case Report.
Ivanova NG
Life (Basel); 2024 May; 14(5):. PubMed ID: 38792634
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment approaches for tumoral calcinosis in children and young people: A condition of diverse pathogenesis.
Anilkumar A; Högler W; Bursell J; Nadar R; Ryan F; Randell T; Shaw NJ; Uday S
Bone; 2024 May; 182():117049. PubMed ID: 38364881
[TBL] [Abstract][Full Text] [Related]
13. Regulation of FGF23 Production in Osteocytes.
Fukumoto S
Curr Osteoporos Rep; 2024 Apr; 22(2):273-279. PubMed ID: 38334918
[TBL] [Abstract][Full Text] [Related]
14. Hyperphosphatemic tumoral calcinosis.
Mallick S; Ahmad Z; Gupta AK; Mathur SR
BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23645700
[TBL] [Abstract][Full Text] [Related]
15. Tumor calcinosis revealing a familial hyperphosphatemic disease.
Yasmine M; Hanene LF; Dorra BN; Zied J; Dhia K; Kaouther M; Mourad J; Wafa H
Int J Rheum Dis; 2023 Aug; 26(8):1619-1621. PubMed ID: 37031367
[No Abstract] [Full Text] [Related]
16. Sedimentation sign: a classical finding on tumorous calcinosis.
Pires V; Cavaca RP; Oliveira RC; Marques C
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35321912
[TBL] [Abstract][Full Text] [Related]
17. Expansion of Phenotypic Spectrum in Hyperphosphatemic Familial Tumoral Calcinosis.
Purushothama G; Bhavani GSL; Shah H; Girisha KM; Handattu K
Indian Pediatr; 2024 Feb; 61(2):186-188. PubMed ID: 38217273
[No Abstract] [Full Text] [Related]
18. Clinical Characteristics and Bone Features of Autosomal Recessive Hypophosphatemic Rickets Type 1 in Three Chinese Families: Report of Five Chinese Cases and Review of the Literature.
Ni X; Li X; Zhang Q; Liu C; Gong Y; Wang O; Li M; Xing X; Jiang Y; Xia W
Calcif Tissue Int; 2020 Dec; 107(6):636-648. PubMed ID: 32920683
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
